Maya Paritsky

Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study

Silvio Danese, Jean‐Frédéric Colombel, Milan Lukáš et al. · ˜The œLancet. Gastroenterology & hepatology · 2021 · 93 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +14

Endothelial Dysfunction Is Reversible in Helicobacter Pylori-Positive Subjects

Arnon Blum, Snait Tamir, Keren Mualem et al. · The American Journal of Medicine · 2011 · 39 citations

Veterinary Medicine, Pathobiology, Physiology +13

Resistance of Helicobacter pylori to tetracycline, amoxicillin, clarithromycin and metronidazole in Israeli children and adults

Avi Peretz, Maya Paritsky, Omar Nasser et al. · The Journal of Antibiotics · 2014 · 37 citations

Life Sciences, Microbiology, Pharmacology +14

GenoType® Helico<scp>DR</scp> test in comparison with histology and culture for <i>Helicobacter pylori</i> detection and identification of resistance mutations to clarithromycin and fluoroquinolones

Nina Pastukh, Dana Binyamin, Avi On et al. · Helicobacter · 2017 · 33 citations

Medicine, Infectious Diseases, Microbiology +17

Association of<i>Streptococcus bovis</i>presence in colonic content with advanced colonic lesion

Maya Paritsky · World Journal of Gastroenterology · 2015 · 24 citations · Full text

Life Sciences, Clinical Sciences, Microbiology +16